Irritable Bowel Syndrome (IBS) Market Report

Global Irritable Bowel Syndrome (IBS) Market is expected to grow at a CAGR of 5.2% during the forecast period.

The global IBS market is segmented on the basis of type into IBD drug, IBC drug, irritable bowel syndrome (IBS), and by application into women and men. The market for women was valued at USD 1,890 million in 2017 and accounted for over 50% share in terms of revenue generated from this segment. This can be attributed to higher incidence rates among females than males across all age groups.

North America dominated the global IBS market with over 40% share in 2017 owing to high prevalence rates among adults as well as increased awareness about the condition among people living in this region. Europe followed North America with over 30% share due to high incidence rates among adults coupled with increasing awareness levels about this condition across countries such as Germany and France which are major contributors towards its growth rate during the forecast period from 2021-2030.

-IBS is a chronic condition that affects the large intestine and causes abdominal pain, bloating, gas, diarrhea or constipation.

-The prevalence of IBS in the United States is estimated to be between 10% and 15%.

-There are many treatments for IBS including medications such as laxatives and antidiarrheals; probiotics; dietary changes such as low FODMAPs diets; psychological therapies such as cognitive behavioral therapy (CBT) and hypnotherapy.
Industry Growth Insights published a new data on “Irritable Bowel Syndrome (IBS) Market”. The research report is titled “Irritable Bowel Syndrome (IBS) Market research by Types (IBS-D Drug, IBS-C Drug, Other, Irritable Bowel Syndrome (IBS), By Applications (Women, Men), By Players/Companies Allergan, Bausch Health, Takeda, Sucampo Pharmaceuticals, McNeil Consumer Healthcare, Sebela Pharmaceuticals, Astellas Pharmaceuticals, IM HealthScience, Irritable Bowel Syndrome (IBS”.
Scope Of The Report
Report Attributes Report Details
Report Title Irritable Bowel Syndrome (IBS) Market Research Report
By Type IBS-D Drug, IBS-C Drug, Other, Irritable Bowel Syndrome (IBS
By Application Women, Men
By Companies Allergan, Bausch Health, Takeda, Sucampo Pharmaceuticals, McNeil Consumer Healthcare, Sebela Pharmaceuticals, Astellas Pharmaceuticals, IM HealthScience, Irritable Bowel Syndrome (IBS
Regions Covered North America, Europe, APAC, Latin America, MEA
Base Year 2021
Historical Year 2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year 2030
Number of Pages 234
Number of Tables & Figures 164
Customization Available Yes, the report can be customized as per your need.

Global Irritable Bowel Syndrome (IBS) Market Report Segments:
The global Irritable Bowel Syndrome (IBS) market is segmented on the basis of:
Types
IBS-D Drug, IBS-C Drug, Other, Irritable Bowel Syndrome (IBS
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Women, Men
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
AllerganBausch HealthTakedaSucampo PharmaceuticalsMcNeil Consumer HealthcareSebela PharmaceuticalsAstellas PharmaceuticalsIM HealthScienceIrritable Bowel Syndrome (IBS

Highlights of The Irritable Bowel Syndrome (IBS) Market Report:
The market structure and projections for the coming years.
Drivers, restraints, opportunities, and current trends of market.
Historical data and forecast.
Estimations for the forecast period 2030.
Developments and trends in the market.
By Type:
IBS-D Drug
IBS-C Drug
Other
Irritable Bowel Syndrome (IBS
By Application:
Women
Men
Market scenario by region, sub-region, and country.
Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Irritable Bowel Syndrome (IBS) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
Correctly Positioning New Products
Market Entry Strategies
Business Expansion Strategies
Consumer Insights
Understanding Competition Scenario
Product & Brand Management
Channel & Customer Management
Identifying Appropriate Advertising Appeals

8 Reasons to Buy This Report
Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
Implemented Robust Methodology to Prepare the Report
Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
Provides Information About the Top-winning Strategies Implemented by Industry Players.
In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
Customization of the Report Available

Frequently Asked Questions?

What is Irritable Bowel Syndrome (IBS)?

Irritable Bowel Syndrome (IBS) is a disorder that causes abdominal pain and discomfort, as well as changes in bowel habits. IBS is thought to be caused by a combination of factors, including genetics and lifestyle choices. Treatment typically includes dietary changes, medication, and therapy.

Who are the key players in the irritable bowel syndrome (ibs) market?

Some of the key players operating in the irritable bowel syndrome (ibs) market are Allergan, Bausch Health, Takeda, Sucampo Pharmaceuticals, McNeil Consumer Healthcare, Sebela Pharmaceuticals, Astellas Pharmaceuticals, IM HealthScience, Irritable Bowel Syndrome (IBS.

What is the growth rate of the irritable bowel syndrome (ibs) market?

The irritable bowel syndrome (ibs) market is expected to register a CAGR of 5.2%.

                                            
                                               1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Irritable Bowel Syndrome (IBS) Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Irritable Bowel Syndrome (IBS) Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Irritable Bowel Syndrome (IBS) Market - Supply Chain
   4.5. Global Irritable Bowel Syndrome (IBS) Market Forecast
      4.5.1. Irritable Bowel Syndrome (IBS) Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Irritable Bowel Syndrome (IBS) Market Size (000 Units) and Y-o-Y Growth
      4.5.3. Irritable Bowel Syndrome (IBS) Market Absolute $ Opportunity

5. Global Irritable Bowel Syndrome (IBS) Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Type
      5.3.1. IBS-D Drug
      5.3.2. IBS-C Drug
      5.3.3. Other
      5.3.4. Irritable Bowel Syndrome (IBS
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Irritable Bowel Syndrome (IBS) Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Application
      6.3.1. Women
      6.3.2. Men
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Irritable Bowel Syndrome (IBS) Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Irritable Bowel Syndrome (IBS) Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Irritable Bowel Syndrome (IBS) Demand Share Forecast, 2019-2026

9. North America Irritable Bowel Syndrome (IBS) Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Application
      9.4.1. Women
      9.4.2. Men
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Type
      9.7.1. IBS-D Drug
      9.7.2. IBS-C Drug
      9.7.3. Other
      9.7.4. Irritable Bowel Syndrome (IBS
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Irritable Bowel Syndrome (IBS) Demand Share Forecast, 2019-2026

10. Latin America Irritable Bowel Syndrome (IBS) Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Application
      10.4.1. Women
      10.4.2. Men
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Type
      10.7.1. IBS-D Drug
      10.7.2. IBS-C Drug
      10.7.3. Other
      10.7.4. Irritable Bowel Syndrome (IBS
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Irritable Bowel Syndrome (IBS) Demand Share Forecast, 2019-2026

11. Europe Irritable Bowel Syndrome (IBS) Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Application
      11.4.1. Women
      11.4.2. Men
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Type
      11.7.1. IBS-D Drug
      11.7.2. IBS-C Drug
      11.7.3. Other
      11.7.4. Irritable Bowel Syndrome (IBS
   11.8. Basis Point Share (BPS) Analyis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Irritable Bowel Syndrome (IBS) Demand Share, 2019-2026

12. Asia Pacific Irritable Bowel Syndrome (IBS) Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Application
      12.4.1. Women
      12.4.2. Men
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Type
      12.7.1. IBS-D Drug
      12.7.2. IBS-C Drug
      12.7.3. Other
      12.7.4. Irritable Bowel Syndrome (IBS
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Irritable Bowel Syndrome (IBS) Demand Share, 2019-2026

13. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Application
      13.4.1. Women
      13.4.2. Men
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size and Volume Forecast by Type
      13.7.1. IBS-D Drug
      13.7.2. IBS-C Drug
      13.7.3. Other
      13.7.4. Irritable Bowel Syndrome (IBS
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Irritable Bowel Syndrome (IBS) Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Irritable Bowel Syndrome (IBS) Market: Market Share Analysis
   14.2. Irritable Bowel Syndrome (IBS) Distributors and Customers
   14.3. Irritable Bowel Syndrome (IBS) Market: Competitive Dashboard
   14.4. Company Profiles (Details  Overview, Financials, Developments, Strategy) 
      14.4.1. Allergan
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Bausch Health
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Takeda
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Sucampo Pharmaceuticals
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. McNeil Consumer Healthcare
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Sebela Pharmaceuticals
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Astellas Pharmaceuticals
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. IM HealthScience
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Irritable Bowel Syndrome (IBS
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Full Name

Work Email

Contact Number

Company Name

Title/Designation

Country

How can we help you?

Report Attributes	Report Details
Report Title	Irritable Bowel Syndrome (IBS) Market Research Report
By Type	IBS-D Drug, IBS-C Drug, Other, Irritable Bowel Syndrome (IBS
By Application	Women, Men
By Companies	Allergan, Bausch Health, Takeda, Sucampo Pharmaceuticals, McNeil Consumer Healthcare, Sebela Pharmaceuticals, Astellas Pharmaceuticals, IM HealthScience, Irritable Bowel Syndrome (IBS
Regions Covered	North America, Europe, APAC, Latin America, MEA
Base Year	2021
Historical Year	2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year	2030
Number of Pages	234
Number of Tables & Figures	164
Customization Available	Yes, the report can be customized as per your need.

	Single User	$ 3300
	Multi User	$ 4200
	Corporate User	$ 5500

Global Irritable Bowel Syndrome (IBS) Market by Type (IBS-D Drug, IBS-C Drug, Other, Irritable Bowel Syndrome (IBS), By Application (Women, Men) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Scope Of The Report

Global Irritable Bowel Syndrome (IBS) Market Report Segments:

Highlights of The Irritable Bowel Syndrome (IBS) Market Report:

IBS-D Drug

IBS-C Drug

Other